BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% ...

AIIMS Delhi has resumed free Therapeutic Drug Monitoring (TDM) tests for epilepsy patients. This initiative reduces financial ...

Bright Minds Biosciences has debuted glowing phase 2 results for its lead anti-seizure asset, giving the biotech’s stock a ...

Pediatric patients with autism spectrum disorder (ASD) hospitalized with acute sinusitis have increased rates of seizures, ...

The first seizure clinic model enabled rapid diagnosis and treatment for children with epilepsy, according to data presented ...

Shares of Bright Minds Biosciences rose after the company released positive topline results from its phase two trial of a treatment for patients with drug-resistant Absence Seizures and Developmental ...

Ceribell’s LVO Stroke is underpinned by the same EEG monitoring technology used in its seizure and delirium monitoring ...

In the case of Tamiflu, new research is offering relief and good news for parents and children. The latest study data ...

Videos that present inaccurate and potentially harmful information about epilepsy drew more views on TikTok than accurate ...

Scientists hope the device can help give patients more warning ahead of seizures and prevent potential injuries ...

A long-running debate over Tamiflu’s safety in children may finally be settled. Researchers found that influenza, not the ...

A 'unique' AI-powered headset that can predict epileptic seizures minutes before they occur has been developed by scientists ...